Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP804198.RA8b0J0eqyCjvlPG12BFbu-ULy7VHGNRWuorWwcyf9m7A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP804198.RA8b0J0eqyCjvlPG12BFbu-ULy7VHGNRWuorWwcyf9m7A130_assertion type Assertion NP804198.RA8b0J0eqyCjvlPG12BFbu-ULy7VHGNRWuorWwcyf9m7A130_head.
- NP804198.RA8b0J0eqyCjvlPG12BFbu-ULy7VHGNRWuorWwcyf9m7A130_assertion description "[To investigate the molecular basis of an experimental combination therapy for malignant gliomas with TRAIL and Troglitazone, we investigated the Troglitazone-induced signaling cascades and the expression of TRAIL receptors and FLIP in malignant gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804198.RA8b0J0eqyCjvlPG12BFbu-ULy7VHGNRWuorWwcyf9m7A130_provenance.
- NP804198.RA8b0J0eqyCjvlPG12BFbu-ULy7VHGNRWuorWwcyf9m7A130_assertion evidence source_evidence_literature NP804198.RA8b0J0eqyCjvlPG12BFbu-ULy7VHGNRWuorWwcyf9m7A130_provenance.
- NP804198.RA8b0J0eqyCjvlPG12BFbu-ULy7VHGNRWuorWwcyf9m7A130_assertion SIO_000772 19158480 NP804198.RA8b0J0eqyCjvlPG12BFbu-ULy7VHGNRWuorWwcyf9m7A130_provenance.
- NP804198.RA8b0J0eqyCjvlPG12BFbu-ULy7VHGNRWuorWwcyf9m7A130_assertion wasDerivedFrom befree-20150227 NP804198.RA8b0J0eqyCjvlPG12BFbu-ULy7VHGNRWuorWwcyf9m7A130_provenance.
- NP804198.RA8b0J0eqyCjvlPG12BFbu-ULy7VHGNRWuorWwcyf9m7A130_assertion wasGeneratedBy ECO_0000203 NP804198.RA8b0J0eqyCjvlPG12BFbu-ULy7VHGNRWuorWwcyf9m7A130_provenance.